All In Biotech

Drug Trial Radar · NCT05568225

A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)

A Phase 2 Open-Label Study to Evaluate Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)

Last checked: Nov 19, 2026Latest source record: Sep 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

17

Actual

Start

Nov 15, 2022

Primary completion

Jul 15, 2024

Study completion Jul 15, 2024

Sponsor

Lead sponsor
Forma Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Oct 5, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of etavopivat (FT-4202) for the treatment of anemia in adult patients with very low risk, low risk, or intermediate risk MDS.

Conditions

  • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R

Interventions

  • EtavopivatDrug

    400 mg once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Hematologic Improvement- Erythroid (HI-E) Response for >=8 Weeks Within 24 Weeks of Etavopivat TreatmentTime frame: From Baseline to Week 24

Locations

10 sites in 4 countries. Site status is shown where the registry gives one.

  • University of Miami Hospital and Clinics

    Miami, Florida

  • Ocala Oncology

    Ocala, Florida

  • NYU Langone Health

    New York, New York

  • Columbia University Irving Medical Center

    New York, New York

  • University of British Columbia - St. Paul's Hospital

    Vancouver, British Columbia, Canada

  • Hopital Saint Louis

    Paris, France

  • Nice University Hospital - Hôpital de l'Archet

    Route de Saint-Antoine, Nice, France

  • Universitoetsklinikum Heidelberg

    Heidelberg, Germany

  • Universitaetsklinikum Muenster

    Münster, Germany

  • Universitoetsklinikum Halle (Saale)

    Münster, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.